UPLIZNA (inebilizumab-cdon)

UPLIZNA (inebilizumab-cdon) is a CD19-directed cytolytic antibody indicated for the treatment of neuromyelitis optica spectrum disorder in adult patients who are anti-aquaporin-4 antibody positive.

www.uplizna.com